Recognized immune markers nevertheless protect their relevance for scientific selection-making in breast most cancers therapy with even prolonged meanings. Estrogen receptor (ER) stage should not only be categorized in constructive or unfavorable. Very low ER degrees ?10% of labeled cells must be handled differently (LoE 1a/A/In the past++). Tumors